MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing
and commercializing treatments for diabetes, announced today that it
will present at The Piper Jaffray 25th Annual Healthcare Conference on
Wednesday, December 4, 2013 at 10:00 AM (ET) at The New York Palace, New
York, New York.
Interested parties can access a link to the live webcast of the
presentations from the News & Events section of the Company's website at http://www.mannkindcorp.com.
About MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) focuses on the discovery,
development and commercialization of therapeutic products for patients
with diseases such as diabetes. Its lead product candidate, AFREZZA®,
has completed Phase 3 clinical trials. MannKind maintains a website at www.mannkindcorp.com
to which MannKind regularly posts copies of its press releases as well
as additional information about MannKind. Interested persons can
subscribe on the MannKind website to e-mail alerts that are sent
automatically when MannKind issues press releases, files its reports
with the Securities and Exchange Commission or posts certain other
information to the website.
Copyright Business Wire 2013